Tags » Pharmaceuticals

Omeros Files Infringement Suits Against Par

Press Release: Omeros Files Infringement Suits Against Par
Omeros Files Infringement Suits Against Par
PR Newswire
SEATTLE, Sept. 3, 2015
SEATTLE, Sept. 3, 2015 /PRNewswire/ — Omeros Corporation (NASDAQ: OMER) today announced that it has filed patent…
Readmore…

INDUSTRIES

Pfizer Completes Acquisition Of Hospira >PFE

Press Release: Pfizer Completes Acquisition of Hospira
Pfizer Completes Acquisition of Hospira

— Creates a leading Global Established Pharmaceutical (GEP) Business

— Expected to be immediately accretive to adjusted diluted EPS1 upon… 6 more words

INDUSTRIES

Press Release: Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference

Press Release: Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference
Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference… 12 more words

INDUSTRIES

Press Release: Point Capital Quarterly Update

Press Release: Point Capital Quarterly Update
Point Capital Quarterly Update
ENGLEWOOD, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) — Point Capital Inc. (OTCQB:PTCI),
“We produced a net increase in net assets resulting from operations for the second consecutive…
Readmore…

INDUSTRIES

Omeros Files Infringement Suits Against Par

Press Release: Omeros Files Infringement Suits Against Par
Omeros Files Infringement Suits Against Par
PR Newswire
SEATTLE, Sept. 3, 2015
SEATTLE, Sept. 3, 2015 /PRNewswire/ — Omeros Corporation (NASDAQ: OMER) today announced that it has filed patent infringement lawsuits against Par Pharmaceutical, Inc. 96 more words

Pharmaceuticals

Omeros Files Infringement Suits Against Par

Press Release: Omeros Files Infringement Suits Against Par
Omeros Files Infringement Suits Against Par
PR Newswire
SEATTLE, Sept. 3, 2015
SEATTLE, Sept. 3, 2015 /PRNewswire/ — Omeros Corporation (NASDAQ: OMER) today announced that it has filed patent infringement lawsuits against Par Pharmaceutical, Inc. 96 more words

Pharmaceuticals

Pfizer Completes Acquisition Of Hospira >PFE

Press Release: Pfizer Completes Acquisition of Hospira
Pfizer Completes Acquisition of Hospira

— Creates a leading Global Established Pharmaceutical (GEP) Business

— Expected to be immediately accretive to adjusted diluted EPS1 upon… 89 more words

Pharmaceuticals